Advancements in Severe Pediatric Asthma Treatment: Insights from Sheba
Dr. Moshe Ashkenazi, a pediatric pulmonologist and Deputy Director at the Edmond and Lily Safra Children’s Hospital at Sheba, highlights the effectiveness of the latest asthma treatments: specialized sprays and biological therapies for maximum control over the disease. Elaborating on these new treatments, Dr. Ashkenazi said that sprays are divided into two categories: sprays for long-term condition management and acute interventions for immediate relief.
Additionally, the development and release of six distinct biological therapies have further expanded treatment options for asthma. Dr. Ashkenazi described these recent developments as a revolutionary step forward for patients with severe asthma, including children.
The Role of Parents in Detection and Treatment
However, despite these advancements, Dr. Ashkenazi notes that approximately 10% of children with severe asthma continue to experience symptoms even after treatment, a situation often arising from incorrect dosing or improper use of prescribed medication.
To address this challenge, Dr. Ashkenazi advises healthcare providers to ensure that parents monitor their children for symptoms such as increased fatigue, avoidance of physical activities or persistent nighttime coughing. Early intervention and accurate treatment adjustments are crucial for managing severe pediatric asthma effectively.
About Sheba’s Safra Pediatric Lung Disease Unit at Edmond & Lily Safra Children’s Hospital
Safra’s Pediatric Lung Disease Unit is at the forefront of treatment innovation and advancement, offering specialized care for infants, children, and adolescents with complex lung conditions. The unit is dedicated to the diagnosis, treatment and monitoring of asthma patients, as well as providing comprehensive training on proper inhaler use, ensuring optimal condition management for children with asthma.
More Posts
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
